Details of the Drug Combinations

General Information of This Drug (ID: DMD7X1O)

Drug Name
Dexrazoxane   DMD7X1O
Synonyms
24584-09-6; Zinecard; (S)-4,4'-(Propane-1,2-diyl)bis(piperazine-2,6-dione); Cardioxane; ICRF-187; Dexrazoxano; Dexrazoxanum; Dextrorazoxane; Dexrazoxanum [INN-Latin]; Dexrazoxano [INN-Spanish]; Desrazoxane; Eucardion; ADR 529; ICRF 187; (+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; Dexrazone; ADR-529; (+)-1,2-Bis(3,5-dioxo-1-piperazinyl)propane; HSDB 7319; UNII-048L81261F; NSC169780; dyzoxane; BRN 5759131; CHEBI:50223; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione; NSC 169780; AK-72797; Razoxanum; Cardioxane; Dyzoxane; Savene; TopoTect; Totect; Dexrazoxane HCl; Dexrazoxane hydrochloride; ICRF 187 hydrochloride; Cardioxane (TN); Dexrazoxane (TN); Totect (TN); Zinecard (TN); Dexrazoxane (USAN/INN); Dexrazoxane [USAN:BAN:INN]; Soluble ICRF (L-isosomer); Razoxane, (S)-Isomer; Totect, ICRF-187, Zinecard, Cardioxane, Dexrazoxane Hydrochloride;(+)-(S)-4,4'-Propylenedi-2,6-piperazinedione; (+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane; (S)-(+)-1,2-Bis(3,5-dioxopiperazin-1-yl)propane; 2,6-Piperazinedione, 4,4'-(1-methyl-1,2-ethanediyl)bis-, (+)-(9CI); 4,4'-(2S)-propane-1,2-diyldipiperazine-2,6-dione; 4-[(2S)-2-(3,5-dioxopiperazin-1-yl)propyl]piperazine-2,6-dione hydrochloride; Icrf-187
Indication
Disease Entry ICD 11 Status REF
Breast cancer 2C60-2C65 Approved [1]
Chemoprotection N.A. Approved [2]
Inflammatory breast cancer 2C62 Approved [3]
Respiratory tract disease CB7Z Investigative [4]
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

593 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Dexrazoxane DCMP8YH ABIRATERONE Glioma (Cell Line: SF-539) [5]
ABIRATERONE + Dexrazoxane DCH645M ABIRATERONE Adenocarcinoma (Cell Line: HCT-15) [6]
ABIRATERONE + Dexrazoxane DCK7QO9 ABIRATERONE Adenocarcinoma (Cell Line: HT29) [6]
Anastrozole + Dexrazoxane DCAZ41K Anastrozole Adenocarcinoma (Cell Line: OVCAR3) [5]
Anastrozole + Dexrazoxane DC4NLZD Anastrozole Adenocarcinoma (Cell Line: SW-620) [5]
Anastrozole + Dexrazoxane DCXCEKO Anastrozole Adenocarcinoma (Cell Line: HCT116) [5]
Anastrozole + Dexrazoxane DCBEBJD Anastrozole Adenocarcinoma (Cell Line: HT29) [5]
Anastrozole + Dexrazoxane DCXFZFC Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Anastrozole + Dexrazoxane DCZ1RMC Anastrozole Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Anastrozole + Dexrazoxane DCUOIUK Anastrozole Anaplastic large cell lymphoma (Cell Line: SR) [5]
Anastrozole + Dexrazoxane DCPBQJG Anastrozole Clear cell renal cell carcinoma (Cell Line: A498) [5]
Anastrozole + Dexrazoxane DCXDTIC Anastrozole Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Anastrozole + Dexrazoxane DC6LMTT Anastrozole Glioma (Cell Line: SF-539) [5]
Anastrozole + Dexrazoxane DC3IMEK Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Anastrozole + Dexrazoxane DCK5U6P Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Anastrozole + Dexrazoxane DCN90UU Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Anastrozole + Dexrazoxane DCOOP9A Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Anastrozole + Dexrazoxane DCB2E45 Anastrozole Malignant melanoma (Cell Line: LOX IMVI) [5]
Anastrozole + Dexrazoxane DC76G7Q Anastrozole Melanoma (Cell Line: MALME-3M) [5]
Anastrozole + Dexrazoxane DCFPXEO Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Anastrozole + Dexrazoxane DC3U4VG Anastrozole Renal cell carcinoma (Cell Line: SN12C) [5]
Anastrozole + Dexrazoxane DCNFXXR Anastrozole Renal cell carcinoma (Cell Line: UO-31) [5]
Anastrozole + Dexrazoxane DCYMOIL Anastrozole Colon adenocarcinoma (Cell Line: COLO 205) [7]
Anastrozole + Dexrazoxane DCF720F Anastrozole Colon carcinoma (Cell Line: KM12) [7]
Anastrozole + Dexrazoxane DCNPD7L Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [7]
BIO-300 + Dexrazoxane DCRZEHO BIO-300 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
BIO-300 + Dexrazoxane DCAL3TM BIO-300 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
BIO-300 + Dexrazoxane DC037T8 BIO-300 Anaplastic large cell lymphoma (Cell Line: SR) [5]
BIO-300 + Dexrazoxane DCVQQ2W BIO-300 Chronic myelogenous leukemia (Cell Line: K-562) [5]
BIO-300 + Dexrazoxane DC7EK3W BIO-300 Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
BIO-300 + Dexrazoxane DCTJ6RI BIO-300 Glioblastoma (Cell Line: SNB-75) [5]
BIO-300 + Dexrazoxane DCZF9AK BIO-300 Colon adenocarcinoma (Cell Line: COLO 205) [7]
BIO-300 + Dexrazoxane DC7VOX4 BIO-300 Invasive ductal carcinoma (Cell Line: BT-549) [7]
BIO-300 + Dexrazoxane DCPT4T2 BIO-300 Invasive ductal carcinoma (Cell Line: HS 578T) [7]
BIO-300 + Dexrazoxane DCG1HEZ BIO-300 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
BIO-300 + Dexrazoxane DCP6UZN BIO-300 Malignant melanoma (Cell Line: UACC62) [6]
Cabazitaxel + Dexrazoxane DCDT8JH Cabazitaxel Adenocarcinoma (Cell Line: HT29) [5]
Cabazitaxel + Dexrazoxane DCEMBQU Cabazitaxel Adenocarcinoma (Cell Line: HCT-15) [5]
Cabazitaxel + Dexrazoxane DCEAC0O Cabazitaxel Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Cabazitaxel + Dexrazoxane DCJNYGO Cabazitaxel Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Cabazitaxel + Dexrazoxane DCFWOVY Cabazitaxel Anaplastic large cell lymphoma (Cell Line: SR) [5]
Cabazitaxel + Dexrazoxane DCISSO8 Cabazitaxel Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Cabazitaxel + Dexrazoxane DCB64JO Cabazitaxel Glioblastoma (Cell Line: SNB-75) [5]
Cabazitaxel + Dexrazoxane DCQ0GGU Cabazitaxel High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Cabazitaxel + Dexrazoxane DCYWEDP Cabazitaxel Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Cabazitaxel + Dexrazoxane DCPL8P6 Cabazitaxel Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Cabazitaxel + Dexrazoxane DCGYIK6 Cabazitaxel Renal cell carcinoma (Cell Line: SN12C) [5]
Cabazitaxel + Dexrazoxane DC1W9N0 Cabazitaxel Carcinoma (Cell Line: RXF 393) [7]
Cabazitaxel + Dexrazoxane DCYCZUN Cabazitaxel Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Crizotinib + Dexrazoxane DC3ASB1 Crizotinib Adenocarcinoma (Cell Line: HCT-15) [5]
Crizotinib + Dexrazoxane DC7UPJH Crizotinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Crizotinib + Dexrazoxane DCOBLDQ Crizotinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Crizotinib + Dexrazoxane DCYRWO1 Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Crizotinib + Dexrazoxane DCH5QDR Crizotinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Crizotinib + Dexrazoxane DC1HAKJ Crizotinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Crizotinib + Dexrazoxane DCRHH5M Crizotinib Invasive ductal carcinoma (Cell Line: T-47D) [7]
Dexrazoxane + Mechlorethamine DC6DF7D Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Mechlorethamine DCWG9CN Mechlorethamine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Mechlorethamine DCF6K8B Mechlorethamine Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Mechlorethamine DC5A2ZB Mechlorethamine Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Mechlorethamine DCQI14E Mechlorethamine Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Picoplatin DCUJ6GH Picoplatin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Picoplatin DCT3MUJ Picoplatin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Picoplatin DC2NHBR Picoplatin Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dexrazoxane + Fulvestrant DCSJSQ1 Fulvestrant Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Fulvestrant DC6RWLM Fulvestrant Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Fulvestrant DCP5SGC Fulvestrant Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Hepzato DCTCEUM Hepzato Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Hepzato DC0AG9C Hepzato Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Hepzato DCERJ1Z Hepzato Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Dactinomycin DC7DK9Y Dactinomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Dactinomycin DCQIMP8 Dactinomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Dactinomycin DCJVEI6 Dactinomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Dactinomycin DCR2GLE Dactinomycin Astrocytoma (Cell Line: SNB-19) [5]
Dexrazoxane + Dactinomycin DCOIWE8 Dactinomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Dactinomycin DCIXDA3 Dactinomycin Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dexrazoxane + Dactinomycin DC0TNEO Dactinomycin Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Dactinomycin DCU1UM1 Dactinomycin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Dactinomycin DCNK1KQ Dactinomycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Lapatinib DCS4CV5 Lapatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Lapatinib DCBJZ4P Lapatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + PMID28460551-Compound-2 DCNJP1G PMID28460551-Compound-2 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + PMID28460551-Compound-2 DC2MOEI PMID28460551-Compound-2 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + PMID28460551-Compound-2 DCVBD8W PMID28460551-Compound-2 Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Cyclophosphamide DCTTHOU Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + LIAROZOLE DCBDUYW LIAROZOLE Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + LIAROZOLE DC9MH7O LIAROZOLE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Methotrexate DCK74MY Methotrexate Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dexrazoxane + Isoniazid DC99003 Isoniazid Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Isoniazid DCAAHOU Isoniazid Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Isoniazid DCEBDA6 Isoniazid Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Isoniazid DCCIOBK Isoniazid Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + Plicamycin DCIFVCJ Plicamycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Plicamycin DC1CXSU Plicamycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Plicamycin DCSZUSY Plicamycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Plicamycin DC3V7JA Plicamycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Plicamycin DC6W5PQ Plicamycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Plicamycin DCMA5UE Plicamycin Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dexrazoxane + Plicamycin DCIADZ5 Plicamycin Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Plicamycin DCI81IH Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Thioguanine DCFF846 Thioguanine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Thioguanine DCRZ9QZ Thioguanine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Thioguanine DC3F1DV Thioguanine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Thioguanine DCLVNX3 Thioguanine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Thioguanine DCVKRR0 Thioguanine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Thioguanine DCHRYH5 Thioguanine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + Thioguanine DC1QQZG Thioguanine Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Thioguanine DCU0PJ7 Thioguanine Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Triapine DC6I5KA Triapine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + 10-hydroxycamptothecin DCTC27D 10-hydroxycamptothecin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + 10-hydroxycamptothecin DC2HVG4 10-hydroxycamptothecin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Topetecan DCNU4DP Topetecan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Amonafide DCXWYM2 Amonafide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Amonafide DCLU4RL Amonafide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Amonafide DC5WJ3G Amonafide Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Amonafide DCSOJ0S Amonafide Astrocytoma (Cell Line: U251) [5]
Dexrazoxane + Amonafide DCEIHBB Amonafide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Amonafide DCGOH7K Amonafide Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Amonafide DCCYSX6 Amonafide Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dexrazoxane + Amonafide DC20PZG Amonafide Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Amonafide DCWBM6B Amonafide Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Amonafide DCLU9JC Amonafide Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Terameprocol DCP2C9O Terameprocol Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Terameprocol DC08A6J Terameprocol Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Terameprocol DCXB04T Terameprocol Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + SCH 727965 DC97S69 SCH 727965 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + SCH 727965 DC4TJDC SCH 727965 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Ifosfamide DCW1NRL Ifosfamide Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Ifosfamide DC8LFP1 Ifosfamide Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Raloxifene DCU4AWS Raloxifene Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Raloxifene DCGDUCI Raloxifene Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Raloxifene DCH5P1U Raloxifene Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Bendamustine hydrochloride DCM64IW Bendamustine hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Bendamustine hydrochloride DCDULKU Bendamustine hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Sirolimus DC0V9MD Sirolimus Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Sirolimus DCVN9WI Sirolimus Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Sirolimus DCQBYNM Sirolimus Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Mitomycin DC7WXOS Mitomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Mitomycin DCXUJ1P Mitomycin Glioma (Cell Line: SF-268) [5]
Dexrazoxane + SY-1425 DC57KXY SY-1425 Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Uracil mustard DCIGWQD Uracil mustard Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Uracil mustard DCUH479 Uracil mustard Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Uracil mustard DCANKH6 Uracil mustard Astrocytoma (Cell Line: SNB-19) [5]
Dexrazoxane + Uracil mustard DCH589E Uracil mustard Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Uracil mustard DC7DS9X Uracil mustard Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dexrazoxane + Uracil mustard DCRKKXC Uracil mustard Glioblastoma (Cell Line: SNB-75) [5]
Dexrazoxane + Uracil mustard DCH4UL3 Uracil mustard Glioma (Cell Line: SF-295) [5]
Dexrazoxane + Uracil mustard DCKSJL9 Uracil mustard Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Vincristine DC9B1RY Vincristine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Vincristine DC7BS8N Vincristine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Vincristine DCUV444 Vincristine Clear cell renal cell carcinoma (Cell Line: A498) [5]
Dexrazoxane + Arfolitixorin DCRP2NI Arfolitixorin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Arfolitixorin DCZ3ARH Arfolitixorin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Arfolitixorin DCW8MHS Arfolitixorin Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Idarubicin DCIMVC4 Idarubicin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Imatinib DCUB7X7 Imatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Bleomycin DC6SQHE Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Bleomycin DC4RZEE Bleomycin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Bleomycin DCXJGV9 Bleomycin Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Bleomycin DCUV45F Bleomycin Astrocytoma (Cell Line: U251) [5]
Dexrazoxane + Bleomycin DCMIRRM Bleomycin Astrocytoma (Cell Line: SNB-19) [5]
Dexrazoxane + Bleomycin DC49UWX Bleomycin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Bleomycin DC0KI6U Bleomycin Chronic myelogenous leukemia (Cell Line: K-562) [5]
Dexrazoxane + Bleomycin DCQ7AOZ Bleomycin Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dexrazoxane + Bleomycin DCOQCEH Bleomycin Glioblastoma (Cell Line: SNB-75) [5]
Dexrazoxane + Bleomycin DCC8N4R Bleomycin Glioma (Cell Line: SF-539) [5]
Dexrazoxane + Bleomycin DCIP6XS Bleomycin Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Bleomycin DCFOZMF Bleomycin Glioma (Cell Line: SF-295) [5]
Dexrazoxane + Bleomycin DC0D80K Bleomycin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Bleomycin DCWG49T Bleomycin Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Bortezomib DCV39FT Bortezomib Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Dacarbazine DCDM3N4 Dacarbazine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Dacarbazine DC2MXH6 Dacarbazine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Dacarbazine DCLYG85 Dacarbazine Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Dexrazoxane + Dacarbazine DCNN62A Dacarbazine Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Dexrazoxane + Dacarbazine DCSLDCT Dacarbazine Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Dacarbazine DCL6CYB Dacarbazine Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Topotecan DCQO4QW Topotecan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Topotecan DC1KJRL Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Topotecan DCY04EN Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + Topotecan DCAIHWX Topotecan Glioblastoma (Cell Line: SNB-75) [5]
Dexrazoxane + Topotecan DCC9ZKZ Topotecan Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Topotecan DCS8TWL Topotecan Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Topotecan DC12OS2 Topotecan Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Cisplatin DCV5YMA Cisplatin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Cisplatin DC0XDXE Cisplatin Glioblastoma (Cell Line: SNB-75) [5]
Dexrazoxane + Cisplatin DCSAX9E Cisplatin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Sorafenib DCXUJVR Sorafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Romidepsin DCZRTXP Romidepsin Adenocarcinoma (Cell Line: SW-620) [5]
Dexrazoxane + Azacitidine DCH9MEI Azacitidine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Azacitidine DCS7L67 Azacitidine Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Pomalidomide DC9LPXA Pomalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Pomalidomide DCHIDTE Pomalidomide Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Pomalidomide DCYHEMM Pomalidomide Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + Pomalidomide DCYMWKI Pomalidomide Glioma (Cell Line: SF-295) [5]
Dexrazoxane + Pomalidomide DC0ZC79 Pomalidomide Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Pomalidomide DCZSPZL Pomalidomide Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Vinflunine DCNZJN1 Vinflunine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Vinflunine DC6OOK0 Vinflunine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Vinflunine DCEDXDY Vinflunine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Vinflunine DCNWR2G Vinflunine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Mercaptopurine DCDWCHN Mercaptopurine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Mercaptopurine DCHEK5J Mercaptopurine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Mercaptopurine DCTYT1Y Mercaptopurine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Mepacrine DCPHWFA Mepacrine Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Dexrazoxane + Fludarabine DC7BZXV Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Fludarabine DC2PDK2 Fludarabine Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Dexrazoxane + PMID28870136-Compound-43 DCTINBA PMID28870136-Compound-43 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + FORMESTANE DCITZS2 FORMESTANE Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + FORMESTANE DCFC2AE FORMESTANE Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DCOX77X Aminolevulinic Acid Hydrochloride Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DCRW49A Aminolevulinic Acid Hydrochloride Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DC28NMA Aminolevulinic Acid Hydrochloride Renal cell carcinoma (Cell Line: SN12C) [5]
Dexrazoxane + Estramustine DCSGCN7 Estramustine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Estramustine DCENJWA Estramustine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Estramustine DCTCFXE Estramustine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Digitoxin DCORI0M Digitoxin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Digitoxin DCTCA5J Digitoxin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Digitoxin DCV95FC Digitoxin Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Busulfan DCEJ2T4 Busulfan Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Busulfan DCZG2OX Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Busulfan DCMYW3J Busulfan Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Busulfan DCVWZSG Busulfan Glioma (Cell Line: SF-268) [5]
Dexrazoxane + Dasatinib DC8OLMY Dasatinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Dexrazoxane + Dasatinib DC3DY1N Dasatinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Dexrazoxane + Dasatinib DC8I1B8 Dasatinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Dexrazoxane + Dasatinib DCSPNNK Dasatinib Astrocytoma (Cell Line: SNB-19) [5]
Dexrazoxane + Dasatinib DC4E1SJ Dasatinib Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Dexrazoxane + Mechlorethamine DCTE1X3 Mechlorethamine Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Picoplatin DCTTHFW Picoplatin Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Picoplatin DCRD96U Picoplatin Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Fulvestrant DCM2ER6 Fulvestrant Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Dactinomycin DCL6KH3 Dactinomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Dactinomycin DCMXSR3 Dactinomycin Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Dactinomycin DCHG8ET Dactinomycin Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Dactinomycin DC5J18O Dactinomycin Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + PMID28460551-Compound-2 DC3358W PMID28460551-Compound-2 Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + PMID28460551-Compound-2 DCEZ8RC PMID28460551-Compound-2 Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + PMID28460551-Compound-2 DCMMBYZ PMID28460551-Compound-2 Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Cyclophosphamide DC43YBL Cyclophosphamide Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + LIAROZOLE DCDGH62 LIAROZOLE Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + LIAROZOLE DCPT2NW LIAROZOLE Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Isoniazid DCI1FKJ Isoniazid Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Plicamycin DCAFZRW Plicamycin Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Plicamycin DCQQ6D4 Plicamycin Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Plicamycin DCE6P1Q Plicamycin Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Plicamycin DCMDXSC Plicamycin Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Plicamycin DCZE2RW Plicamycin Invasive ductal carcinoma (Cell Line: T-47D) [7]
Dexrazoxane + Plicamycin DCZBKKJ Plicamycin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Thioguanine DC5AO6U Thioguanine Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Thioguanine DCO7R0J Thioguanine Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Thioguanine DCBUHU8 Thioguanine Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Amonafide DCST2BW Amonafide Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Amonafide DCF2O13 Amonafide Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Amonafide DCH8JHY Amonafide Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Terameprocol DC5S9Q2 Terameprocol Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Ifosfamide DC4RZK9 Ifosfamide Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Ifosfamide DCSFKJ5 Ifosfamide Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Ifosfamide DCDFI7C Ifosfamide Invasive ductal carcinoma (Cell Line: T-47D) [7]
Dexrazoxane + Raloxifene DCS9R55 Raloxifene Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Raloxifene DC77CLZ Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Bendamustine hydrochloride DCPYG7F Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Sirolimus DC2DQJN Sirolimus Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Letrozole DCBQ881 Letrozole Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Mitomycin DCE4OD3 Mitomycin Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Mitomycin DCGDMHM Mitomycin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + SY-1425 DCS7DJ2 SY-1425 Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Uracil mustard DC9ATAS Uracil mustard Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Uracil mustard DCVU73Y Uracil mustard Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Uracil mustard DCMMWBR Uracil mustard Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Arfolitixorin DCRTHFJ Arfolitixorin Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Arfolitixorin DCB5S85 Arfolitixorin Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Arfolitixorin DC10U80 Arfolitixorin Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Arfolitixorin DCGDL6W Arfolitixorin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Altretamine DCP2XHG Altretamine Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Bleomycin DCKLQOT Bleomycin Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Bleomycin DCXM80C Bleomycin Carcinoma (Cell Line: RXF 393) [7]
Dexrazoxane + Bleomycin DCVVOAF Bleomycin Carcinoma (Cell Line: MCF7) [7]
Dexrazoxane + Bleomycin DCAJEDQ Bleomycin Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Bleomycin DCYQULA Bleomycin Invasive ductal carcinoma (Cell Line: T-47D) [7]
Dexrazoxane + Bleomycin DC1K7Y9 Bleomycin Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Bleomycin DCS74O3 Bleomycin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Bortezomib DCNZVC7 Bortezomib Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Dacarbazine DC9419N Dacarbazine Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Valrubicin DCF08EK Valrubicin Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Topotecan DC4YS83 Topotecan Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Dexrazoxane + Topotecan DCN4OL1 Topotecan Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Cisplatin DC62I8L Cisplatin Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Cisplatin DC3Q82R Cisplatin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + ER819762 DC5D4VM ER819762 Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Romidepsin DCOIAZ6 Romidepsin Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Pomalidomide DCNSJ27 Pomalidomide Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Vinflunine DC2ZA2O Vinflunine Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Mercaptopurine DCWPZBL Mercaptopurine Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + Mepacrine DCN3RCX Mepacrine Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + PMID28870136-Compound-43 DC5SVAF PMID28870136-Compound-43 Colon carcinoma (Cell Line: KM12) [7]
Dexrazoxane + FORMESTANE DC648R7 FORMESTANE Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DCVSYU5 Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DCDK6IJ Aminolevulinic Acid Hydrochloride Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Estramustine DCJCNB4 Estramustine Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Busulfan DCACPAN Busulfan Colon adenocarcinoma (Cell Line: COLO 205) [7]
Dexrazoxane + Busulfan DCNASI5 Busulfan Invasive ductal carcinoma (Cell Line: BT-549) [7]
Dexrazoxane + Busulfan DC9T2KH Busulfan Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Dexrazoxane + Dasatinib DCJ2WJG Dasatinib Carcinoma (Cell Line: MCF7) [7]
Dexrazoxane + Mechlorethamine DCTYD32 Mechlorethamine Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Mechlorethamine DCPC4UF Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Mechlorethamine DCHWF7E Mechlorethamine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Mechlorethamine DCF2FWX Mechlorethamine Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Picoplatin DC6TAXI Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Picoplatin DC22OES Picoplatin Malignant melanoma (Cell Line: UACC62) [6]
Dexrazoxane + Picoplatin DC2WMFP Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Fulvestrant DCKDUPT Fulvestrant Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Fulvestrant DCYOH6G Fulvestrant Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Hepzato DCPAZ43 Hepzato Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Hepzato DCL23F7 Hepzato Lung adenocarcinoma (Cell Line: HOP-62) [6]
Dexrazoxane + Hepzato DCPHNN9 Hepzato Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Dactinomycin DCJLD06 Dactinomycin Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Dactinomycin DC0ZVD8 Dactinomycin Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Dactinomycin DCLIEL1 Dactinomycin Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Dactinomycin DC1Q8V3 Dactinomycin Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + Dactinomycin DCNTE3W Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Dexrazoxane + Dactinomycin DCFXNGN Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Dactinomycin DCDHPM6 Dactinomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Dactinomycin DCYTOWJ Dactinomycin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Dactinomycin DCUFIMA Dactinomycin Lung adenocarcinoma (Cell Line: EKVX) [6]
Dexrazoxane + Dactinomycin DCEH0BU Dactinomycin Lung adenocarcinoma (Cell Line: NCI-H522) [6]
Dexrazoxane + Dactinomycin DC8GDJ0 Dactinomycin Malignant melanoma (Cell Line: LOX IMVI) [6]
Dexrazoxane + Dactinomycin DCV6X67 Dactinomycin Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Dactinomycin DCT0SXY Dactinomycin Melanoma (Cell Line: SK-MEL-2) [6]
Dexrazoxane + Dactinomycin DC7DVYH Dactinomycin Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Dactinomycin DCQBX30 Dactinomycin Non-small cell lung carcinoma (Cell Line: HOP-92) [6]
Dexrazoxane + Dactinomycin DCCOEVH Dactinomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Dexrazoxane + DFN-15 DCEN28C DFN-15 Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Lapatinib DCCUOVY Lapatinib Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Lapatinib DCI3I53 Lapatinib Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Lapatinib DC4GDII Lapatinib Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + PMID28460551-Compound-2 DCKTS6Z PMID28460551-Compound-2 Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + PMID28460551-Compound-2 DCMKFV2 PMID28460551-Compound-2 Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Dexrazoxane + PMID28460551-Compound-2 DCTNFW7 PMID28460551-Compound-2 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + PMID28460551-Compound-2 DCMH0CE PMID28460551-Compound-2 Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + PMID28460551-Compound-2 DCIKNNK PMID28460551-Compound-2 Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Dexrazoxane + Crizotinib DCTQVRI Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Crizotinib DCZ6J3K Crizotinib Malignant melanoma (Cell Line: LOX IMVI) [6]
Dexrazoxane + Crizotinib DCZDMBG Crizotinib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Cyclophosphamide DCL1KT5 Cyclophosphamide Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Methotrexate DC64R63 Methotrexate Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Dexrazoxane + Methotrexate DCWTX8V Methotrexate Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Dexrazoxane + Isoniazid DC3VX0E Isoniazid Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Isoniazid DCTKJ0P Isoniazid Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Isoniazid DCWJVBZ Isoniazid Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + Isoniazid DCOBXTZ Isoniazid Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Isoniazid DC8NYWU Isoniazid Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Isoniazid DCM75CL Isoniazid High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Arsenic trioxide DC75L66 Arsenic trioxide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Arsenic trioxide DCWZY16 Arsenic trioxide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Vemurafenib DCEJAV2 Vemurafenib Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Vemurafenib DC5YFHX Vemurafenib Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Vemurafenib DCJVUY4 Vemurafenib Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Plicamycin DCPYEDW Plicamycin Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Plicamycin DC9GSPC Plicamycin Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Plicamycin DCBKGCV Plicamycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Dexrazoxane + Plicamycin DCR9ZVA Plicamycin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Plicamycin DC2WA1C Plicamycin Lung adenocarcinoma (Cell Line: NCI-H522) [6]
Dexrazoxane + Plicamycin DCO661E Plicamycin Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Nilotinib DCC8I1V Nilotinib Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Nilotinib DCGGIRY Nilotinib Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Nilotinib DCZM39Z Nilotinib Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Thioguanine DC3RYFP Thioguanine Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Dexrazoxane + Thioguanine DCXCT2G Thioguanine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Thioguanine DC60QNN Thioguanine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Thioguanine DCQ6SRQ Thioguanine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Triapine DCULCHQ Triapine Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + 10-hydroxycamptothecin DC28H93 10-hydroxycamptothecin Adenocarcinoma (Cell Line: DU-145) [6]
Dexrazoxane + 10-hydroxycamptothecin DCDMOSE 10-hydroxycamptothecin Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Amonafide DCWQCOT Amonafide Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Dexrazoxane + Amonafide DC8GXLC Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Amonafide DC0ZC1P Amonafide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Amonafide DCG92IZ Amonafide High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Amonafide DC7N1ZO Amonafide Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Amonafide DCS11A4 Amonafide Malignant melanoma (Cell Line: LOX IMVI) [6]
Dexrazoxane + Amonafide DCW3T3D Amonafide Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Amonafide DCSEE3U Amonafide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Dexrazoxane + Pralatrexate DCPFC9A Pralatrexate Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Terameprocol DCSVNIF Terameprocol Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Terameprocol DCHKJL3 Terameprocol Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Terameprocol DCW9VVX Terameprocol Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Terameprocol DCAXL5N Terameprocol Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + SCH 727965 DC92L20 SCH 727965 Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + SCH 727965 DCZGZUU SCH 727965 Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + SCH 727965 DC0YMH3 SCH 727965 Amelanotic melanoma (Cell Line: M14) [6]
Dexrazoxane + Ifosfamide DCDQK9O Ifosfamide Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Ifosfamide DCEOD44 Ifosfamide Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Ifosfamide DC9QFPU Ifosfamide Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Ifosfamide DCOV65W Ifosfamide Melanoma (Cell Line: SK-MEL-2) [6]
Dexrazoxane + Docetaxel DCVYDJP Docetaxel Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Raloxifene DC7TWWJ Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + Raloxifene DCZME8D Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Raloxifene DCGK6IQ Raloxifene Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Raloxifene DCTC615 Raloxifene Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Dexrazoxane + Bendamustine hydrochloride DC0RMID Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Bendamustine hydrochloride DCI6IP5 Bendamustine hydrochloride Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Bendamustine hydrochloride DCC27QL Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Sirolimus DCMXPMH Sirolimus Adenocarcinoma (Cell Line: NCIH23) [6]
Dexrazoxane + Mitomycin DCA0GEN Mitomycin Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Mitomycin DCDB3LN Mitomycin Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Mitomycin DCUSVS8 Mitomycin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + SY-1425 DCA03W0 SY-1425 Amelanotic melanoma (Cell Line: MDA-MB-435) [6]
Dexrazoxane + SY-1425 DCW2OML SY-1425 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Dexrazoxane + Uracil mustard DCKF60B Uracil mustard Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Dexrazoxane + Uracil mustard DC05J8I Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Uracil mustard DCX9UWS Uracil mustard Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Dexrazoxane + Vincristine DCD22N9 Vincristine Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Vincristine DCSQAAB Vincristine Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Vincristine DCM7DXS Vincristine Amelanotic melanoma (Cell Line: M14) [6]
Dexrazoxane + Arfolitixorin DCLY15B Arfolitixorin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Arfolitixorin DCGH78C Arfolitixorin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Arfolitixorin DCP3DNS Arfolitixorin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Altretamine DC1MD7R Altretamine Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Dexrazoxane + Altretamine DC6J5C7 Altretamine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + TEM DCQZE67 TEM Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Imatinib DC6HFRD Imatinib Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Imatinib DC7H860 Imatinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Bleomycin DCXWL8B Bleomycin Adenocarcinoma (Cell Line: DU-145) [6]
Dexrazoxane + Bleomycin DCHKORY Bleomycin Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Bleomycin DC4T6H2 Bleomycin Adenocarcinoma (Cell Line: HCC-2998) [6]
Dexrazoxane + Bleomycin DCXC9B2 Bleomycin Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Bleomycin DC5C9SU Bleomycin Adenocarcinoma (Cell Line: HCT-15) [6]
Dexrazoxane + Bleomycin DC4ZGI8 Bleomycin Amelanotic melanoma (Cell Line: M14) [6]
Dexrazoxane + Bleomycin DC2QFTK Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Dexrazoxane + Bleomycin DC8ZDTK Bleomycin Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Dexrazoxane + Bleomycin DCDA8MV Bleomycin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Bleomycin DC7VZKC Bleomycin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Bleomycin DC1QT8A Bleomycin Lung adenocarcinoma (Cell Line: HOP-62) [6]
Dexrazoxane + Bleomycin DC7U4JQ Bleomycin Lung adenocarcinoma (Cell Line: NCI-H522) [6]
Dexrazoxane + Bleomycin DC75FA9 Bleomycin Malignant melanoma (Cell Line: UACC62) [6]
Dexrazoxane + Bleomycin DC4PIVY Bleomycin Malignant melanoma (Cell Line: LOX IMVI) [6]
Dexrazoxane + Bleomycin DCBEI0C Bleomycin Melanoma (Cell Line: SK-MEL-2) [6]
Dexrazoxane + Bleomycin DCUD8M4 Bleomycin Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Bleomycin DC0JXLD Bleomycin Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Bleomycin DC9QT4W Bleomycin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Bleomycin DCXXT5N Bleomycin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Dexrazoxane + Bleomycin DCDOJCP Bleomycin Prostate carcinoma (Cell Line: PC-3) [6]
Dexrazoxane + Bortezomib DCLKTMT Bortezomib Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Bortezomib DCE4WQQ Bortezomib Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Bortezomib DCG5J2E Bortezomib Lung adenocarcinoma (Cell Line: HOP-62) [6]
Dexrazoxane + Dacarbazine DCVFRJO Dacarbazine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Topotecan DCQ9JYV Topotecan Adenocarcinoma (Cell Line: OVCAR3) [6]
Dexrazoxane + Topotecan DC3M7N1 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Dexrazoxane + Topotecan DCRKGAT Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [6]
Dexrazoxane + Topotecan DCLM791 Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Topotecan DCNK5CW Topotecan High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [6]
Dexrazoxane + Topotecan DCKALVC Topotecan Lung adenocarcinoma (Cell Line: EKVX) [6]
Dexrazoxane + Topotecan DC23PKH Topotecan Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Topotecan DCBVZTH Topotecan Melanoma (Cell Line: UACC-257) [6]
Dexrazoxane + Topotecan DC7HPO6 Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Topotecan DCQYNO1 Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [6]
Dexrazoxane + Topotecan DC6EQAL Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Dexrazoxane + Cisplatin DCXNC45 Cisplatin Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Cisplatin DC6HKBE Cisplatin Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Cisplatin DCA6943 Cisplatin Amelanotic melanoma (Cell Line: MDA-MB-435) [6]
Dexrazoxane + Cisplatin DC60ALG Cisplatin Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Dexrazoxane + Cisplatin DCGMVCJ Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + Cisplatin DC2IRLA Cisplatin Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Cisplatin DCG7WT1 Cisplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Cisplatin DCZR9EX Cisplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Chlorambucil DCKMCNW Chlorambucil Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + ER819762 DCPR0IP ER819762 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Dexrazoxane + ER819762 DCOJB13 ER819762 Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [6]
Dexrazoxane + Romidepsin DCYGFAR Romidepsin Lung adenocarcinoma (Cell Line: MDA-MB-231) [6]
Dexrazoxane + Romidepsin DC3I8JM Romidepsin Lung adenocarcinoma (Cell Line: EKVX) [6]
Dexrazoxane + Romidepsin DC8OJ6W Romidepsin Malignant melanoma (Cell Line: LOX IMVI) [6]
Dexrazoxane + Romidepsin DC8510S Romidepsin Melanoma (Cell Line: MALME-3M) [6]
Dexrazoxane + Azacitidine DCLAEJ3 Azacitidine Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Azacitidine DC00T5O Azacitidine Amelanotic melanoma (Cell Line: MDA-MB-435) [6]
Dexrazoxane + Azacitidine DCVCKWF Azacitidine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Azacitidine DCOHOSB Azacitidine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Pomalidomide DCPH0UH Pomalidomide Adenocarcinoma (Cell Line: HT29) [6]
Dexrazoxane + Pomalidomide DCI22I3 Pomalidomide Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Pomalidomide DCXTCWJ Pomalidomide Adenocarcinoma (Cell Line: SW-620) [6]
Dexrazoxane + Pomalidomide DCIYIU1 Pomalidomide Lung adenocarcinoma (Cell Line: EKVX) [6]
Dexrazoxane + Pomalidomide DCZQD0L Pomalidomide Malignant melanoma (Cell Line: UACC62) [6]
Dexrazoxane + Mercaptopurine DCWK2SJ Mercaptopurine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + Mercaptopurine DCOW8SG Mercaptopurine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Fludarabine DC577E8 Fludarabine Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Dexrazoxane + FORMESTANE DCD2UVP FORMESTANE Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Aminolevulinic Acid Hydrochloride DCV5S0E Aminolevulinic Acid Hydrochloride Melanoma (Cell Line: SK-MEL-2) [6]
Dexrazoxane + Estramustine DCCJUTA Estramustine Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Digitoxin DCGQWGD Digitoxin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [6]
Dexrazoxane + Digitoxin DCAHLF0 Digitoxin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [6]
Dexrazoxane + Busulfan DCWQJUJ Busulfan Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Dasatinib DCVWBLZ Dasatinib Adenocarcinoma (Cell Line: A549) [6]
Dexrazoxane + Dasatinib DCTVI6F Dasatinib Adenocarcinoma (Cell Line: HCT116) [6]
Dexrazoxane + Dasatinib DC4PVWK Dasatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [6]
Epirubicin + Dexrazoxane DC6QYDA Epirubicin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [5]
Epirubicin + Dexrazoxane DCRBVMU Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [5]
Epirubicin + Dexrazoxane DCO8EMY Epirubicin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Epirubicin + Dexrazoxane DCFMNZ7 Epirubicin Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Epirubicin + Dexrazoxane DC851HP Epirubicin Carcinoma (Cell Line: RXF 393) [7]
Epirubicin + Dexrazoxane DCNBMU2 Epirubicin Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Epirubicin + Dexrazoxane DCK86Q5 Epirubicin Adenocarcinoma (Cell Line: HCT-15) [6]
Epirubicin + Dexrazoxane DC15D1Q Epirubicin Adenocarcinoma (Cell Line: HT29) [6]
Epirubicin + Dexrazoxane DC0JLOQ Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [6]
Epirubicin + Dexrazoxane DC02E2A Epirubicin Lung adenocarcinoma (Cell Line: HOP-62) [6]
Epirubicin + Dexrazoxane DCUL30L Epirubicin Melanoma (Cell Line: UACC-257) [6]
Gefitinib + Dexrazoxane DCYFIC6 Gefitinib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Gefitinib + Dexrazoxane DCN7LI4 Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [5]
Gefitinib + Dexrazoxane DCPFXIQ Gefitinib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Gefitinib + Dexrazoxane DCJGKCL Gefitinib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Gefitinib + Dexrazoxane DCAH5E1 Gefitinib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Gefitinib + Dexrazoxane DC5HL48 Gefitinib Glioma (Cell Line: SF-268) [5]
Gefitinib + Dexrazoxane DCGE1UM Gefitinib Glioma (Cell Line: SF-539) [5]
Gefitinib + Dexrazoxane DCHVN40 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Gefitinib + Dexrazoxane DCFKSO2 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Gefitinib + Dexrazoxane DCJQMJ0 Gefitinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Gefitinib + Dexrazoxane DCT8NGX Gefitinib Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Gefitinib + Dexrazoxane DCF5YHN Gefitinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Gefitinib + Dexrazoxane DCLKMA9 Gefitinib Malignant melanoma (Cell Line: LOX IMVI) [5]
Gefitinib + Dexrazoxane DC0GS3G Gefitinib Melanoma (Cell Line: SK-MEL-2) [5]
Gefitinib + Dexrazoxane DCB8VHI Gefitinib Melanoma (Cell Line: UACC-257) [5]
Gefitinib + Dexrazoxane DCFZ1D0 Gefitinib Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Gefitinib + Dexrazoxane DCTNANE Gefitinib Prostate carcinoma (Cell Line: PC-3) [5]
Gefitinib + Dexrazoxane DCDWB8I Gefitinib Renal cell carcinoma (Cell Line: UO-31) [5]
Gefitinib + Dexrazoxane DCN8F6Y Gefitinib Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Gefitinib + Dexrazoxane DC3UO77 Gefitinib Colon adenocarcinoma (Cell Line: COLO 205) [7]
Indazole derivative 5 + Dexrazoxane DCYT7UX Indazole derivative 5 Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Indazole derivative 5 + Dexrazoxane DCR4H8W Indazole derivative 5 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Indazole derivative 5 + Dexrazoxane DCSM097 Indazole derivative 5 Anaplastic large cell lymphoma (Cell Line: SR) [5]
Indazole derivative 5 + Dexrazoxane DCJSI9A Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Indazole derivative 5 + Dexrazoxane DCQT1SP Indazole derivative 5 Adenocarcinoma (Cell Line: HCT116) [6]
Indazole derivative 5 + Dexrazoxane DCQJ4NZ Indazole derivative 5 Adenocarcinoma (Cell Line: HCT-15) [6]
Indazole derivative 5 + Dexrazoxane DC099RO Indazole derivative 5 Adenocarcinoma (Cell Line: HT29) [6]
Indazole derivative 5 + Dexrazoxane DC3I94A Indazole derivative 5 Lung adenocarcinoma (Cell Line: HOP-62) [6]
Lenalidomide + Dexrazoxane DC60882 Lenalidomide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Lenalidomide + Dexrazoxane DCEU6XM Lenalidomide Anaplastic large cell lymphoma (Cell Line: SR) [5]
Lenalidomide + Dexrazoxane DCC18RB Lenalidomide Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Lenalidomide + Dexrazoxane DCJM84P Lenalidomide Clear cell renal cell carcinoma (Cell Line: A498) [5]
Lenalidomide + Dexrazoxane DCF6XTE Lenalidomide Glioma (Cell Line: SF-539) [5]
Lenalidomide + Dexrazoxane DCTA3J6 Lenalidomide Glioma (Cell Line: SF-268) [5]
Lenalidomide + Dexrazoxane DCY8LXN Lenalidomide Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Lenalidomide + Dexrazoxane DCEFOB4 Lenalidomide Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Lenalidomide + Dexrazoxane DCQF1KP Lenalidomide Carcinoma (Cell Line: RXF 393) [7]
Lenalidomide + Dexrazoxane DCGOKI4 Lenalidomide Colon adenocarcinoma (Cell Line: COLO 205) [7]
Lenalidomide + Dexrazoxane DCMFBU8 Lenalidomide Invasive ductal carcinoma (Cell Line: BT-549) [7]
Lenalidomide + Dexrazoxane DCIZQEU Lenalidomide Adenocarcinoma (Cell Line: HCT116) [6]
Lenalidomide + Dexrazoxane DCFIBK1 Lenalidomide Amelanotic melanoma (Cell Line: M14) [6]
Lenalidomide + Dexrazoxane DCNQM85 Lenalidomide Large cell lung carcinoma (Cell Line: NCI-H460) [6]
Lenalidomide + Dexrazoxane DCGSIYS Lenalidomide Lung adenocarcinoma (Cell Line: NCI-H522) [6]
Lenalidomide + Dexrazoxane DCM4TDK Lenalidomide Malignant melanoma (Cell Line: LOX IMVI) [6]
Raloxifene + Dexrazoxane DCNZQ26 Raloxifene Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Raloxifene + Dexrazoxane DCCI8AC Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [5]
Raloxifene + Dexrazoxane DCA0YTG Raloxifene Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Raloxifene + Dexrazoxane DC39VR5 Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [7]
Raloxifene + Dexrazoxane DCHAU3B Raloxifene Adenocarcinoma (Cell Line: HCC-2998) [6]
Raloxifene + Dexrazoxane DC7J1JZ Raloxifene Adenocarcinoma (Cell Line: SW-620) [6]
Raloxifene + Dexrazoxane DCH8K8Z Raloxifene Melanoma (Cell Line: UACC-257) [6]
Ruxolitinib + Dexrazoxane DCSKAIL Ruxolitinib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Ruxolitinib + Dexrazoxane DCCNYBA Ruxolitinib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Ruxolitinib + Dexrazoxane DCMRCVQ Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [7]
Ruxolitinib + Dexrazoxane DCXNVGV Ruxolitinib Adenocarcinoma (Cell Line: A549) [6]
Ruxolitinib + Dexrazoxane DC1GWG6 Ruxolitinib Adenocarcinoma (Cell Line: HCT-15) [6]
Trifluridine + Dexrazoxane DCE2197 Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Trifluridine + Dexrazoxane DCC416F Trifluridine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Trifluridine + Dexrazoxane DCEL3FW Trifluridine Anaplastic large cell lymphoma (Cell Line: SR) [5]
Trifluridine + Dexrazoxane DCSZA1A Trifluridine Chronic myelogenous leukemia (Cell Line: K-562) [5]
Trifluridine + Dexrazoxane DCGC7EZ Trifluridine Glioma (Cell Line: SF-268) [5]
Trifluridine + Dexrazoxane DCFB0W6 Trifluridine Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Trifluridine + Dexrazoxane DCKSNCW Trifluridine Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Trifluridine + Dexrazoxane DC5QVSI Trifluridine Colon adenocarcinoma (Cell Line: COLO 205) [7]
Trifluridine + Dexrazoxane DCMPP1M Trifluridine Adenocarcinoma (Cell Line: SW-620) [6]
Trifluridine + Dexrazoxane DCXHZOM Trifluridine Lung adenocarcinoma (Cell Line: HOP-62) [6]
Trifluridine + Dexrazoxane DCGDW6F Trifluridine Malignant melanoma (Cell Line: LOX IMVI) [6]
Trifluridine + Dexrazoxane DCLDLZW Trifluridine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [6]
Vandetanib + Dexrazoxane DC2Y879 Vandetanib Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Vandetanib + Dexrazoxane DC5T7EG Vandetanib Adenocarcinoma (Cell Line: A549) [6]
Vandetanib + Dexrazoxane DC73WJG Vandetanib Adenocarcinoma (Cell Line: SW-620) [6]
Vandetanib + Dexrazoxane DCXDCG6 Vandetanib Adenocarcinoma (Cell Line: HT29) [6]
Vandetanib + Dexrazoxane DC556PR Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [6]
Vandetanib + Dexrazoxane DCT9YZV Vandetanib Adenocarcinoma (Cell Line: HCT-15) [6]
Vandetanib + Dexrazoxane DCLEIU3 Vandetanib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [6]
Vandetanib + Dexrazoxane DCX5HF4 Vandetanib Anaplastic large cell lymphoma (Cell Line: SR) [6]
Vemurafenib + Dexrazoxane DCAY238 Vemurafenib Breast adenocarcinoma (Cell Line: MDA-MB-468) [7]
Vemurafenib + Dexrazoxane DCJNVWT Vemurafenib Colon adenocarcinoma (Cell Line: COLO 205) [7]
Vemurafenib + Dexrazoxane DCZN75E Vemurafenib Invasive ductal carcinoma (Cell Line: HS 578T) [7]
Vemurafenib + Dexrazoxane DC9A563 Vemurafenib Adenocarcinoma (Cell Line: HCT-15) [6]
Vemurafenib + Dexrazoxane DCONYNU Vemurafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [6]
Vemurafenib + Dexrazoxane DC9JJL8 Vemurafenib Amelanotic melanoma (Cell Line: M14) [6]
Vemurafenib + Dexrazoxane DCL114G Vemurafenib Clear cell renal cell carcinoma (Cell Line: CAKI-1) [6]
Vemurafenib + Dexrazoxane DC57H0M Vemurafenib Cutaneous melanoma (Cell Line: SK-MEL-5) [6]
Vemurafenib + Dexrazoxane DC01N7V Vemurafenib Glioma (Cell Line: SF-539) [6]
Vemurafenib + Dexrazoxane DCEDVQR Vemurafenib Malignant melanoma (Cell Line: LOX IMVI) [6]
Vemurafenib + Dexrazoxane DCGVF3Z Vemurafenib Melanoma (Cell Line: UACC-257) [6]
Vemurafenib + Dexrazoxane DC19SAM Vemurafenib Melanoma (Cell Line: MALME-3M) [6]
Vismodegib + Dexrazoxane DCDKAJI Vismodegib Renal cell carcinoma (Cell Line: UO-31) [6]
------------------------------------------------------------------------------------
⏷ Show the Full List of 593 DrugCom(s)
2 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Cyclophosphamide + Dexrazoxane DC7GMDM Cyclophosphamide Ewing's Sarcoma [8]
Dexrazoxane + Doxorubicin DC0C2N6 Doxorubicin Sarcoma, Soft Tissue [9]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7330).
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
3 Dexrazoxane FDA Label
4 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
5 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
6 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
7 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
8 ClinicalTrials.gov (NCT00038142) Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients
9 ClinicalTrials.gov (NCT02584309) Doxorubicin With Upfront Dexrazoxane for the Treatment of Advanced or Metastatic Soft Tissue Sarcoma